Recent Quotes
My Watchlist
Indicators
Local Stocks
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Autolus Therapeutics Plc ADR (NQ: AUTL )

2.940 +0.100 (+3.52%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Autolus Therapeutics Plc ADR

< Previous 1 2 3 4 Next >
This InterContinental Hotels Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Via Benzinga
Nvidia To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
A Glimpse Into The Expert Outlook On Autolus Therapeutics Through 5 Analysts
Via Benzinga
Breaking Down Autolus Therapeutics: 4 Analysts Share Their Views
Via Benzinga
Autolus Therapeutics's Earnings Outlook
Via Benzinga
AUTL Stock Earnings: Autolus Therapeutics Misses EPS for Q2 2024
AUTL stock results show that Autolus Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget
Since wealth without health is utterly meaningless, investors may have some confidence with these biotech stocks to buy. 
Via InvestorPlace
Crude Oil Gains 1%; GameStop Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Why Cracker Barrel Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Analyst Expectations for Autolus Therapeutics's Future
Via Benzinga
Where Autolus Therapeutics Stands With Analysts
Via Benzinga
Preview: Autolus Therapeutics's Earnings
Via Benzinga
AUTL Stock Earnings: Autolus Therapeutics Misses EPS, Misses Revenue for Q1 2024
AUTL stock results show that Autolus Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
The Latest Analyst Ratings for Autolus Therapeutics
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Earnings Scheduled For March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
Via Benzinga
Chart Of The Day: Autolus Therapeutics - Effective Cancer Treatments
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. 
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Autolus Therapeutics' Obe-Cel's Shows Compelling Safety Over Gilead's Drug For Acute Lymphoblastic Leukemia
Truist has raised the price target for Autolus Therapeutics PLC (NASDAQ: AUTL) from $6 to $9  
Via Benzinga
3 Top Penny Stock Picks You Haven’t Heard Of
Here are three penny stock picks investors likely haven't heard of, but probably should keep on the radar as speculative options. 
Via InvestorPlace
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.